Gene · 4547
Papers2,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cardiac Metabolism and MiRNA Interference. | Int J Mol Sci | 2022 | 36613495 | PubTator, text mining | PubMed |
| Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies. | Cancers (Basel) | 2022 | 36612019 | PubTator, text mining | PubMed |
| Preparation of microgel co-loaded with nuciferine and epigallocatechin-3-gallate for the regulation of lipid metabolism. | Front Nutr | 2022 | 36579075 | PubTator, text mining | PubMed |
| Risk Factors for Nonalcoholic Fatty Liver Disease with Different Insulin Resistance in a Nonobese Chinese Population. | J Diabetes Res | 2022 | 36568964 | PubTator, text mining | PubMed |
| Unraveling the Molecular Mechanisms Involved in HCV-Induced Carcinogenesis. | Viruses | 2022 | 36560766 | PubTator, text mining | PubMed |
| Mechanism Underlying Naringenin Hypocholesterolemic Effects: Involvement of Estrogen Receptor α Subtype. | Int J Mol Sci | 2022 | 36555447 | PubTator, text mining | PubMed |
| Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta gene as a tumour suppressor in stomach adenocarcinoma. | Front Oncol | 2022 | 36518312 | PubTator, text mining | PubMed |
| Investigating microRNAs to Explain the Link between Cholesterol Metabolism and NAFLD in Humans: A Systematic Review. | Nutrients | 2022 | 36500981 | PubTator, text mining | PubMed |
| Role of potential bioactive metabolites from traditional Chinese medicine for type 2 diabetes mellitus: An overview. | Front Pharmacol | 2022 | 36479195 | PubTator, text mining | PubMed |
| Mechanism of action of Orthosiphon stamineus against non-alcoholic fatty liver disease: Insights from systems pharmacology and molecular docking approaches. | Saudi Pharm J | 2022 | 36465851 | PubTator, text mining | PubMed |
| In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis. | Sci Rep | 2022 | 36433987 | PubTator, text mining | PubMed |
| Association between the rs3812316 Single Nucleotide Variant of the MLXIPL Gene and Alpha-Linolenic Acid Intake with Triglycerides in Mexican Mestizo Women. | Nutrients | 2022 | 36432414 | PubTator, text mining | PubMed |
| New Trends and Therapies for Familial Hypercholesterolemia. | J Clin Med | 2022 | 36431115 | PubTator, text mining | PubMed |
| Allicin and Capsaicin Ameliorated Hypercholesterolemia by Upregulating LDLR and Downregulating PCSK9 Expression in HepG2 Cells. | Int J Mol Sci | 2022 | 36430776 | PubTator, text mining | PubMed |
| Mitochondrial Fatty Acid β-Oxidation Disorders: From Disease to Lipidomic Studies-A Critical Review. | Int J Mol Sci | 2022 | 36430419 | PubTator, text mining | PubMed |
| Gut Microbiota-Assisted Synthesis, Cellular Interactions and Synergistic Perspectives of Equol as a Potent Anticancer Isoflavone. | Pharmaceuticals (Basel) | 2022 | 36422548 | PubTator, text mining | PubMed |
| Familial Hypercholesterolemia and Its Current Diagnostics and Treatment Possibilities: A Literature Analysis. | Medicina (Kaunas) | 2022 | 36422206 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis reveals novel key biomarkers in diabetic nephropathy. | SAGE Open Med | 2022 | 36385790 | PubTator, text mining | PubMed |
| World Heart Federation Cholesterol Roadmap 2022. | Glob Heart | 2022 | 36382159 | PubTator, text mining | PubMed |
Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan. | BMJ Open | 2022 | 36375977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4547/papers?page=19